Puma Biotechnology Inc. (PBYI) Financials Nov 17,
Post# of 250602
Posted On: 11/18/2014 9:03:11 AM
Puma Biotechnology Inc. (PBYI) Financials Nov 17, 2014, 4:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Puma Biotechnology Inc.
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 10,702 265,000 423,000
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 10,702 265,000 423,000
Depreciation - 0 10,702 - 423,000
Amortization of Intangibles - 0 0 - 0
Gross Income - 0 (10,702) (265,000) (423,000)
2010 2011 2012 2013 5-year trend
SG&A Expense - 6,931 10.15M 55.99M 54.41M
Research & Development - 0 826,372 49.64M 45.05M
Other SG&A - 6,931 9.32M 6.35M 9.36M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 18.2M 0
EBIT after Unusual Expense - 0 0 (18.2M) 0
Non Operating Income/Expense - 0 (80,000) 0 2,000
Non-Operating Interest Income - - 3,783 98,000 172,000
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income - (6,931) (10.23M) (74.35M) (54.66M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (6,931) (10.23M) (74.35M) (54.66M)
Minority Interest Expense - 0 0 0 0
Net Income - (6,931) (10.23M) (74.35M) (54.66M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (6,931) (10.23M) (74.35M) (54.66M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (6,931) (10.23M) (74.35M) (54.66M)
EPS (Basic) - () (1.32) (3.42) (1.90)
Basic Shares Outstanding - 4M 7.75M 21.73M 28.7M
EPS (Diluted) - () (1.32) (3.42) (1.90)
Diluted Shares Outstanding - 4M 7.75M 21.73M 28.7M
EBITDA - (6,931) (10.15M) (55.99M) (54.41M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Puma Biotechnology Inc.
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 10,702 265,000 423,000
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 10,702 265,000 423,000
Depreciation - 0 10,702 - 423,000
Amortization of Intangibles - 0 0 - 0
Gross Income - 0 (10,702) (265,000) (423,000)
2010 2011 2012 2013 5-year trend
SG&A Expense - 6,931 10.15M 55.99M 54.41M
Research & Development - 0 826,372 49.64M 45.05M
Other SG&A - 6,931 9.32M 6.35M 9.36M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 18.2M 0
EBIT after Unusual Expense - 0 0 (18.2M) 0
Non Operating Income/Expense - 0 (80,000) 0 2,000
Non-Operating Interest Income - - 3,783 98,000 172,000
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income - (6,931) (10.23M) (74.35M) (54.66M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (6,931) (10.23M) (74.35M) (54.66M)
Minority Interest Expense - 0 0 0 0
Net Income - (6,931) (10.23M) (74.35M) (54.66M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (6,931) (10.23M) (74.35M) (54.66M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (6,931) (10.23M) (74.35M) (54.66M)
EPS (Basic) - () (1.32) (3.42) (1.90)
Basic Shares Outstanding - 4M 7.75M 21.73M 28.7M
EPS (Diluted) - () (1.32) (3.42) (1.90)
Diluted Shares Outstanding - 4M 7.75M 21.73M 28.7M
EBITDA - (6,931) (10.15M) (55.99M) (54.41M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼